![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Lai
Verkställande Direktör på
METIS TECHBIO CO., LTD.
Förmögenhet: 289 M $ per 2026-06-30
Profil
Dr. Christopher Lai is a Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., a General Manager & Executive Director at Metis Pharmaceuticals and a Chief Executive Officer at METiS Therapeutics, Inc. He is on the Board of Directors at Metis Pharmaceuticals.
Dr. Lai was previously employed as a Chief Technology Officer by AquaFresco, Inc.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-10 | 111 166 572 ( 10,26 % ) | 218 M $ | 2026-06-30 | |
METIS TECHBIO CO., LTD. 36,55 % | 2026-05-13 | 36 400 278 ( 36,55 % ) | 71 M $ | 2026-06-30 |
Aktiva positioner av Christopher Lai
| Företag | Position | Start |
|---|---|---|
| METIS TECHBIO CO., LTD. | Verkställande Direktör | 2020-01-10 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Verkställande Direktör | - |
Tidigare kända positioner av Christopher Lai
| Företag | Position | Slut |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
